Want to see HLF full AI Analyst Report?
HLF Stock Chart & Stats
$17.02
-$0.10(-1.50%)
At close: 4:00 PM EST
$17.02
-$0.10(-1.50%)
Day’s Range― - ―
52-Week Range$7.56 - $20.40
Previous CloseN/A
Volume468.97K
Average Volume (3M)1.70M
Market Cap
$1.23B
Enterprise Value$917.84M
Total Cash (Recent Filing)$451.20M
Total Debt (Recent Filing)$164.40M
Price to Earnings (P/E)5.2
Beta0.47
Next Earnings
Aug 05, 2026EPS Estimate
0.62Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.33
Shares Outstanding103,669,420
10 Day Avg. Volume1,658,766
30 Day Avg. Volume1,696,278
Financial Highlights & Ratios
PEG Ratio-0.47
Price to Book (P/B)-2.57
Price to Sales (P/S)0.26
P/FCF Ratio5.24
Enterprise Value/Market Cap0.74
Enterprise Value/Revenue0.18
Enterprise Value/Gross Profit0.24
Enterprise Value/Ebitda1.47
Forecast
1Y Price Target
$21.00Price Target Upside23.38% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)2.67
Revenue Forecast (FY)$5.24B
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationHerbalife's TTM operating cash flow ($447M) and free cash flow ($374M, +47.8%) show durable cash conversion. Persistent FCF supports capex, refinancing, debt paydown and M&A funding without relying excessively on new equity, improving long-term financial flexibility.
Material Refinancing And Interest SavingsThe $1.45B senior secured refinancing with extended maturities and ~$45M annual interest savings reduces rollover risk and lowers ongoing financing costs. This structural improvement supports management's plan to cut net leverage below 2.0x and enhances balance sheet stability over multiple years.
Shift To Personalized NutritionTargeted acquisitions and capitalized SaaS investment indicate a deliberate move into personalized, digitally enabled nutrition. This builds differentiated products and distributor tools, which can sustainably improve product mix, distributor retention and medium-term margin profile.
Bears Say
Negative Shareholders' EquityA persistent equity deficit (TTM -$442M) signals accumulated losses or capital structure strain that limits financial flexibility. Even with lower nominal debt, negative equity heightens downside risk, complicates access to unsecured financing and can amplify stress in tougher operating environments.
Compressed Operating MarginsOperating profitability has meaningfully compressed versus earlier years, reducing the earnings cushion for cost shocks or reinvestment. Lower EBITDA/net margins constrain free cash flow upside and raise reliance on structural cost or mix improvements to sustain long-term earnings growth.
India GST Regulatory HeadwindA structural GST timing/mismatch in India is expected to cause a recurring ~$20–$25M EBITDA drag, eroding margins despite strong local volume growth. This regulatory/tax friction creates ongoing G&A and margin pressure and raises complexity in realizing India-driven profitability gains.
Herbalife News
HLF FAQ
What was Herbalife Ltd’s price range in the past 12 months?
Herbalife Ltd lowest stock price was $7.56 and its highest was $20.40 in the past 12 months.
What is Herbalife Ltd’s market cap?
Herbalife Ltd’s market cap is $1.23B.
When is Herbalife Ltd’s upcoming earnings report date?
Herbalife Ltd’s upcoming earnings report date is Aug 05, 2026 which is in 30 days.
How were Herbalife Ltd’s earnings last quarter?
Herbalife Ltd released its earnings results on May 06, 2026. The company reported $0.64 earnings per share for the quarter, beating the consensus estimate of $0.607 by $0.033.
Is Herbalife Ltd overvalued?
According to Wall Street analysts Herbalife Ltd’s price is currently Undervalued.
Does Herbalife Ltd pay dividends?
Herbalife Ltd pays a Quarterly dividend of $0.15 which represents an annual dividend yield of N/A. See more information on Herbalife Ltd dividends here
What is Herbalife Ltd’s EPS estimate?
Herbalife Ltd’s EPS estimate is 0.62.
How many shares outstanding does Herbalife Ltd have?
Herbalife Ltd has 103,669,420 shares outstanding.
What happened to Herbalife Ltd’s price movement after its last earnings report?
Herbalife Ltd reported an EPS of $0.64 in its last earnings report, beating expectations of $0.607. Following the earnings report the stock price went down -11.861%.
Which hedge fund is a major shareholder of Herbalife Ltd?
Currently, no hedge funds are holding shares in HLF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Herbalife Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$21.00 (23.38% Upside)
$21.00 (23.38% Upside)
Blogger Sentiment
Bullish
HLF Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 1.3M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $2.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 3.7%
Last 30 Days ▼ 3.7%
Technicals
SMA
Negative
20 days / 200 days
Momentum
34.73%
12-Months-Change
Fundamentals
Return on Equity
-43.03%
Trailing 12-Months
Asset Growth
7.11%
Trailing 12-Months
Company Description
Herbalife Ltd
Herbalife Nutrition Ltd. is a global enterprise dedicated to providing comprehensive nutritional solutions. Its market presence extends across various international regions, including North America, Mexico, Central and South America, Europe, the Middle East, Africa, China, and the broader Asia Pacific area. The company’s extensive product catalog caters to several core wellness categories, encompassing weight management, specialized nutritional supplementation, energy and athletic performance, and external personal care. Specifically, its weight management offerings feature items like meal replacements, protein shakes, powdered drink mixes, weight loss aids, and healthy snacks. For targeted nutrition, Herbalife provides functional beverages alongside dietary and nutritional supplements rich in herbs, vitamins, minerals, and other naturally derived ingredients. The outer nutrition range includes products for facial, body, and hair care, while its energy, sports, and fitness segment includes popular items such as N-R-G tea and various energy drinks. In addition to its product lines, Herbalife furnishes supporting materials, which comprise start-up kits, sales tools, informational literature, and educational resources. The company employs a multi-channel distribution strategy, primarily leveraging independent service providers and sales representatives, alongside its own company-operated retail platforms. Founded in Los Angeles, California, in 1980, the organization was known as Herbalife Ltd. until April 2018, when it officially rebranded to Herbalife Nutrition Ltd.
HLF Company Deck
HLF Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized clear operational and financial progress—including net sales and adjusted EBITDA beating guidance, strong India performance, meaningful refinancing savings (~$45M annualized), improved cash generation ($114M operating cash flow), and strategic M&A and digital initiatives to accelerate personalized nutrition. Offsetting these positives were region-specific challenges: softness in EMEA and North America (weather and timing), a notable decline in China (volume -18%), modest gross margin pressure from mix and input cost dynamics, and an expected $20–25M FY EBITDA headwind from India GST mismatches. On balance, the company presented multiple durable positives that outweighed the localized and timing-related headwinds, while setting conservative guidance assumptions for FX and tax impacts.View all HLF earnings summariesHLF Net sales Breakdown
33.86% APAC
22.35% North America
21.11% EMEA
16.22% Latin America
6.47% China
HLF Stock 12 Month Forecast
Average Price Target
$21.00
▲(23.38% Upside)
Technical Analysis
Central Garden Pet
―
J & J Snack Foods
―
Simply Good Foods
―
Nature's Sunshine Products
―
USANA Health
―
Ownership Overview
2.86% Insiders
21.69% Mutual Funds
44.47% Other Institutional Investors
10.32% Public Companies and
Individual Investors